Annual EBITDA:
$156.68M+$140.38M(+861.21%)Summary
- As of today, NUTX annual EBITDA is $156.68 million, with the most recent change of +$140.38 million (+861.21%) on December 31, 2024.
- During the last 3 years, NUTX annual EBITDA has fallen by -$24.90 million (-13.71%).
- NUTX annual EBITDA is now -13.71% below its all-time high of $181.58 million, reached on December 31, 2021.
Performance
NUTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$38.93M-$38.37M(-49.64%)Summary
- As of today, NUTX quarterly EBITDA is $38.93 million, with the most recent change of -$38.37 million (-49.64%) on June 30, 2025.
- Over the past year, NUTX quarterly EBITDA has increased by +$22.42 million (+135.88%).
- NUTX quarterly EBITDA is now -67.44% below its all-time high of $119.56 million, reached on December 31, 2024.
Performance
NUTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$250.84M+$22.42M(+9.82%)Summary
- As of today, NUTX TTM EBITDA is $250.84 million, with the most recent change of +$22.42 million (+9.82%) on June 30, 2025.
- Over the past year, NUTX TTM EBITDA has increased by +$215.98 million (+619.45%).
- NUTX TTM EBITDA is now at all-time high.
Performance
NUTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NUTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +861.2% | +135.9% | +619.5% |
| 3Y3 Years | -13.7% | +526.9% | +131.9% |
| 5Y5 Years | +3611.9% | +2546.8% | +4195.1% |
NUTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -13.7% | +1718.2% | -67.4% | +248.5% | at high | +1101.1% |
| 5Y | 5-Year | -13.7% | +3611.9% | -67.4% | +248.5% | at high | +1101.1% |
| All-Time | All-Time | -13.7% | +3611.9% | -67.4% | +248.5% | at high | +1101.1% |
NUTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $38.93M(-49.6%) | $250.84M(+9.8%) |
| Mar 2025 | - | $77.30M(-35.3%) | $228.42M(+45.7%) |
| Dec 2024 | $156.68M(+861.2%) | $119.56M(+693.8%) | $156.75M(+241.1%) |
| Sep 2024 | - | $15.06M(-8.7%) | $45.96M(+31.8%) |
| Jun 2024 | - | $16.50M(+192.8%) | $34.87M(+57.2%) |
| Mar 2024 | - | $5.64M(-35.7%) | $22.18M(+35.7%) |
| Dec 2023 | $16.30M(+89.2%) | $8.76M(+120.7%) | $16.35M(+218.9%) |
| Sep 2023 | - | $3.97M(+4.0%) | $5.13M(+120.5%) |
| Jun 2023 | - | $3.81M(+2071.2%) | -$25.06M(-10.6%) |
| Mar 2023 | - | -$193.50K(+92.1%) | -$22.66M(-345.6%) |
| Dec 2022 | $8.62M(-95.3%) | -$2.46M(+90.6%) | $9.23M(+66.7%) |
| Sep 2022 | - | -$26.22M(-522.2%) | $5.53M(-94.9%) |
| Jun 2022 | - | $6.21M(-80.4%) | $108.16M(-17.9%) |
| Mar 2022 | - | $31.69M(+615.0%) | $131.77M(+37.3%) |
| Dec 2021 | $181.58M(+5628.0%) | -$6.15M(-108.1%) | $96.00M(-5.8%) |
| Sep 2021 | - | $76.41M(+156.2%) | $101.88M(+310.0%) |
| Jun 2021 | - | $29.83M(+830.2%) | $24.85M(+478.3%) |
| Mar 2021 | - | -$4.08M(-1415.7%) | -$6.57M(-100.0%) |
| Dec 2020 | -$3.28M(+26.4%) | -$269.50K(+56.8%) | -$3.28M(+46.4%) |
| Sep 2020 | - | -$623.70K(+60.8%) | -$6.13M(+4.4%) |
| Jun 2020 | - | -$1.59M(-98.7%) | -$6.41M(-2.4%) |
| Mar 2020 | - | -$800.50K(+74.3%) | -$6.25M(+1.5%) |
| Dec 2019 | -$4.46M(-431.2%) | - | - |
| Dec 2019 | - | -$3.11M(-243.6%) | -$6.35M(-75.0%) |
| Sep 2019 | - | -$905.20K(+37.1%) | -$3.63M(-24.4%) |
| Jun 2019 | - | -$1.44M(-60.1%) | -$2.92M(-62.6%) |
| Mar 2019 | - | -$898.50K(-131.5%) | -$1.79M(-58.3%) |
| Dec 2018 | -$839.90K(+53.8%) | -$388.20K(-101.6%) | -$1.13M(-52.1%) |
| Sep 2018 | - | -$192.60K(+38.8%) | -$744.80K(+20.6%) |
| Jun 2018 | - | -$314.60K(-32.4%) | -$938.30K(+39.3%) |
| Mar 2018 | - | -$237.60K(+38.5%) | -$1.55M(-6.0%) |
| Dec 2017 | -$1.82M | - | - |
| Sep 2017 | - | -$386.10K(+58.2%) | -$1.46M(-27.0%) |
| Jun 2017 | - | -$922.70K(-514.3%) | -$1.15M(-295.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$150.20K(-98.7%) | -$290.30K(+40.3%) |
| Dec 2016 | -$448.10K(+15.8%) | - | - |
| Sep 2016 | - | -$75.60K(-17.2%) | -$485.90K(+8.7%) |
| Jun 2016 | - | -$64.50K(+60.1%) | -$532.00K(-3.4%) |
| Mar 2016 | - | -$161.80K(+12.1%) | -$514.70K(-4.0%) |
| Dec 2015 | -$532.30K(+31.4%) | -$184.00K(-51.2%) | -$494.80K(+13.1%) |
| Sep 2015 | - | -$121.70K(-157.8%) | -$569.40K(+9.7%) |
| Jun 2015 | - | -$47.20K(+66.7%) | -$630.90K(+19.5%) |
| Mar 2015 | - | -$141.90K(+45.1%) | -$783.80K(-1.0%) |
| Dec 2014 | -$775.60K(-7.6%) | -$258.60K(-41.2%) | -$775.70K(-50.0%) |
| Sep 2014 | - | -$183.20K(+8.4%) | -$517.10K(-5.4%) |
| Jun 2014 | - | -$200.10K(-49.6%) | -$490.50K(-7.8%) |
| Mar 2014 | - | -$133.80K(+14.6%) | -$454.90K(+65.0%) |
| Dec 2013 | -$720.70K(+50.4%) | - | - |
| Sep 2013 | - | -$156.60K(+4.8%) | -$1.30M(+2.0%) |
| Jun 2013 | - | -$164.50K(+18.2%) | -$1.32M(+4.3%) |
| Mar 2013 | - | -$201.10K(+74.1%) | -$1.39M(+4.7%) |
| Dec 2012 | -$1.45M(-73.3%) | -$776.50K(-324.8%) | -$1.45M(-58.8%) |
| Sep 2012 | - | -$182.80K(+18.6%) | -$915.10K(+5.7%) |
| Jun 2012 | - | -$224.60K(+16.7%) | -$970.10K(-3.4%) |
| Mar 2012 | - | -$269.50K(-13.1%) | -$938.10K(-11.9%) |
| Dec 2011 | -$838.70K(+37.6%) | -$238.20K(-0.2%) | -$838.60K(+19.4%) |
| Sep 2011 | - | -$237.80K(-23.5%) | -$1.04M(+6.9%) |
| Jun 2011 | - | -$192.60K(-13.3%) | -$1.12M(+7.2%) |
| Mar 2011 | - | -$170.00K(+61.4%) | -$1.20M(+10.4%) |
| Dec 2010 | -$1.34M(-96.8%) | -$440.30K(-39.7%) | -$1.34M(-4.2%) |
| Sep 2010 | - | -$315.20K(-12.9%) | -$1.29M(-13.9%) |
| Jun 2010 | - | -$279.20K(+9.9%) | -$1.13M(-19.3%) |
| Mar 2010 | - | -$310.00K(+19.8%) | -$949.90K(-39.2%) |
| Dec 2009 | -$683.40K(-248.3%) | -$386.60K(-145.8%) | -$682.40K(-130.7%) |
| Sep 2009 | - | -$157.30K(-63.9%) | -$295.80K(-113.6%) |
| Jun 2009 | - | -$96.00K(-125.9%) | -$138.50K(-225.9%) |
| Mar 2009 | - | -$42.50K | -$42.50K |
| Dec 2008 | -$196.20K | - | - |
FAQ
- What is Nutex Health Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Nutex Health Inc.?
- What is Nutex Health Inc. annual EBITDA year-on-year change?
- What is Nutex Health Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Nutex Health Inc.?
- What is Nutex Health Inc. quarterly EBITDA year-on-year change?
- What is Nutex Health Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Nutex Health Inc.?
- What is Nutex Health Inc. TTM EBITDA year-on-year change?
What is Nutex Health Inc. annual EBITDA?
The current annual EBITDA of NUTX is $156.68M
What is the all-time high annual EBITDA for Nutex Health Inc.?
Nutex Health Inc. all-time high annual EBITDA is $181.58M
What is Nutex Health Inc. annual EBITDA year-on-year change?
Over the past year, NUTX annual EBITDA has changed by +$140.38M (+861.21%)
What is Nutex Health Inc. quarterly EBITDA?
The current quarterly EBITDA of NUTX is $38.93M
What is the all-time high quarterly EBITDA for Nutex Health Inc.?
Nutex Health Inc. all-time high quarterly EBITDA is $119.56M
What is Nutex Health Inc. quarterly EBITDA year-on-year change?
Over the past year, NUTX quarterly EBITDA has changed by +$22.42M (+135.88%)
What is Nutex Health Inc. TTM EBITDA?
The current TTM EBITDA of NUTX is $250.84M
What is the all-time high TTM EBITDA for Nutex Health Inc.?
Nutex Health Inc. all-time high TTM EBITDA is $250.84M
What is Nutex Health Inc. TTM EBITDA year-on-year change?
Over the past year, NUTX TTM EBITDA has changed by +$215.98M (+619.45%)